Home / Resource Library / LONG TERM FOLLOW-UP OF PATIENTS WITH MANTLE CELL LYMPHOMA, WHO UNDERWENT HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS HEMATOPOIETIC CELL TRANSPLANTATION IN FIRST REMISSION
LONG TERM FOLLOW-UP OF PATIENTS WITH MANTLE CELL LYMPHOMA, WHO UNDERWENT HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS HEMATOPOIETIC CELL TRANSPLANTATION IN FIRST REMISSION